Clinical Performance of Technetium-99meSestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice EDITORIAL COMMENT
The Journal of urology（2023）
摘要
Further work is needed to define utility of technetium-99m-sestamibi in real-world clinical practice. Our data suggest this imaging strategy is not yet ready to replace biopsy.
更多查看译文
关键词
renal cell carcinoma,oncocytic tumors,spect/ct imaging,technetium-99m–sestamibi spect/ct
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要